<DOC>
	<DOCNO>NCT00875355</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-ray kill tumor cell . Drugs use chemotherapy , temozolomide , work different way stop growth tumor cell , either kill cell stop dividing . It yet know whether radiation therapy effective give alone together temozolomide treat brain metastasis secondary breast cancer . PURPOSE : This randomized phase II trial study well radiation therapy give together temozolomide work compare radiation therapy give alone treat woman brain metastasis breast cancer .</brief_summary>
	<brief_title>Radiation Therapy With Without Temozolomide Treating Women With Brain Metastases Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Compare objective response rate 6 week woman brain metastasis secondary breast cancer treat radiotherapy v without temozolomide . Secondary - Evaluate tolerability . - Compare duration response . - Compare local progression-free survival . - Compare overall survival . OUTLINE : This multicenter study . Patients randomize 1 2 treatment arm . - Arm I : Patients undergo isocentric radiotherapy brain 5 time week 2 week . - Arm II : Patients undergo radiotherapy arm I receive oral temozolomide daily 2 week . After completion study treatment , patient follow 3 6 month every 6 month 2 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis breast cancer Unresectable disease patient refuse surgery Must brain metastasis PATIENT CHARACTERISTICS : WHO performance status 02 ANC ≥ 1,500/mm³ Platelet count ≥ 100,000/mm³ Liver transaminase ≤ 1.5 time upper limit normal ( ULN ) Creatinine &lt; 1.5 time ULN Not pregnant nursing Fertile patient must use effective contraception No carcinomatous meningitis No history cancer except basal cell carcinoma skin carcinoma situ cervix No serious concurrent disease , opinion investigator , likely interfere study evaluation treatment No contraindication treatment temozolomide No psychological , familial , social , geographic situation preclude clinical follow No patient deprive liberty guardianship PRIOR CONCURRENT THERAPY : No prior brain radiotherapy At least 10 day since prior chemotherapy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>tumor metastatic brain</keyword>
	<keyword>stage IV breast cancer</keyword>
</DOC>